Holen Sie sich die Stockscreener-App
2.29
3.62%
0.08
Handel nachbörslich:
2.26
-0.03
-1.31%
Schlusskurs vom Vortag:
$2.21
Offen:
$2.18
24-Stunden-Volumen:
77,041
Relative Volume:
0.82
Marktkapitalisierung:
$95.54M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-2.181
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
+1.33%
1M Leistung:
-4.18%
6M Leistung:
-15.19%
1J Leistung:
-7.66%
1-Tages-Spanne:
$2.18
$2.35
1-Wochen-Bereich:
$2.095
$2.41
52-Wochen-Spanne:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.29 | 92.20M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD, Inc. Appoints Peter A. Soukas, M.D., as Chief Medical Officer - MarketScreener
Applying chart zones and confluence areas to InspireMD Inc.2025 Top Gainers & Safe Entry Momentum Tips - newser.com
Why analysts remain bullish on InspireMD Inc. stockPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Why InspireMD Inc. (II2) stock remains top ratedQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is InspireMD Inc. stock poised for growth2025 Year in Review & Stock Portfolio Risk Control - newser.com
Using data filters to optimize entry into InspireMD Inc.2025 Momentum Check & Real-Time Market Trend Scan - newser.com
InspireMD appoints Dr. Peter Soukas as chief medical officer - Investing.com
InspireMD Appoints Dr. Peter A. Soukas as Chief Medical Officer to Advance Carotid Intervention Initiatives - Quiver Quantitative
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer - The Manila Times
InspireMD (NASDAQ: NSPR) names Dr. Peter Soukas CMO as CGuard Prime launches in U.S. - Stock Titan
How InspireMD Inc. stock reacts to Fed rate cuts2025 Big Picture & Scalable Portfolio Growth Methods - newser.com
Can InspireMD Inc. stock weather global recessionMarket Activity Report & AI Driven Stock Reports - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersWeekly Stock Recap & High Accuracy Buy Signal Tips - newser.com
What to do if you’re stuck in InspireMD Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Short interest data insights for InspireMD Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsTrade Exit Summary & Proven Capital Preservation Tips - newser.com
Backtesting results for InspireMD Inc. trading strategiesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
What margin trends mean for InspireMD Inc. stockWeekly Stock Report & Community Consensus Stock Picks - newser.com
How InspireMD Inc. (II2) stock responds to job market shiftsEarnings Miss & Technical Entry and Exit Alerts - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollar2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Pleasing Signs As A Number Of Insiders Buy InspireMD Stock - Yahoo Finance
Is InspireMD Inc. stock a defensive play in 2025July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Can InspireMD Inc. stock resist market sell offsJuly 2025 Decliners & Target Return Focused Picks - newser.com
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):